INSYS THERAPEUTICS

insys-therapeutics-logo

Insys Therapeutics is a commercial-stage specialty pharmaceutical company that develops and commercializes innovative supportive care products. We have two marketed products, Subsys and Dronabinol SG Capsule, which leverage our sublingual spray drug delivery technology and dronabinol formulation and manufacturing capabilities, respectively. In March 2012, we launched Subsys, our proprietary sublingual fentanyl spray for breakthrough cancer pain, or BTCP, in opioid-tolerant patients.

#People #Website #More

INSYS THERAPEUTICS

Social Links:

Industry:
Biotechnology Manufacturing Medical Pharmaceutical

Founded:
1990-06-01

Address:
Chandler, Arizona, United States

Country:
United States

Website Url:
http://www.insysrx.com

Total Employee:
501+

Status:
Closed

Contact:
6029102627

Total Funding:
2.32 M USD

Technology used in webpage:
Domain Not Resolving IPv6 CDN JS Google Google Maps API Google Cloud Cloudflare Hosting ASP.NET WP Engine Google Cloud Iowa


Current Employees Featured

not_available_image

John Kapoor
John Kapoor Founder @ Insys Therapeutics
Founder

not_available_image

Michael L. Babich
Michael L. Babich CEO @ Insys Therapeutics
CEO

not_available_image

Larry Dillaha
Larry Dillaha CMO @ Insys Therapeutics
CMO

Founder


not_available_image

John Kapoor

Stock Details


Company's stock symbol is NASDAQ:INSY

Official Site Inspections

http://www.insysrx.com

  • Host name: a2aa9ff50de748dbe.awsglobalaccelerator.com
  • IP address: 3.33.130.190
  • Location: Seattle United States
  • Latitude: 47.6348
  • Longitude: -122.3451
  • Metro Code: 819
  • Timezone: America/Los_Angeles
  • Postal: 98109

Loading ...

More informations about "Insys Therapeutics"

Insys Therapeutics 2025 Company Profile: Valuation, Investors ...

Insys Therapeutics General Information Description. Developer of biopharmaceutical products based in Chandler, Arizona. The company develops and commercializes innovative drugs and โ€ฆSee details»

Insys Therapeutics - Wikipedia

Insys Therapeutics was an American specialty pharmaceutical company based in Chandler, Arizona in 1990. Its main product was Subsys, a sublingual liquid form of the drug fentanyl. Fentanyl is an extremely fast-acting and powerful opioid used to relieve breakthrough pain in cancer patients, and prescription of fentanyl in the US for such pain usually requires documented failure of more conservative therapies. See details»

Insys Therapeutics - Crunchbase Company Profile & Funding

Insys Therapeutics is a commercial-stage specialty pharmaceutical company that develops and commercializes innovative supportive care products.See details»

Insys Therapeutics

Feb 25, 2025 Insys Therapeutics, Inc. was incorporated in 2011 and is based in Chandler, Arizona. It was founded by pharmaceutical entrepreneur John Kapoor when he purchased the โ€ฆSee details»

Insys Therapeutics Inc - AnnualReports.com

Insys Therapeutics, Inc., a specialty pharmaceutical company, develops and commercializes supportive care products. The company markets Subsys, a proprietary sublingual fentanyl โ€ฆSee details»

Insys Therapeutics Inc - Company Overview, Contact Info, โ€ฆ

Insysrx.com Phone (480) 500-3127 Employees 72 Founded in 1998 Industry Materials/Manufacturing Stock Symbol NASDAQ:INS. More Details. Financials & Stats . โ€ฆSee details»

www.insysrx.com

Www.insysrx.comSee details»

Insys Therapeutics - Company info. interviews, news

Jul 28, 2021 Antisense Oligonucleotides Make Sense July 28, 2021 Antisense oligonucleotides (ASOs) are short (about 12 to 25 nucleotides long), synthetic single strands of DNA or RNA โ€ฆSee details»

Insys Therapeutics - Craft

Mar 25, 2020 Insys Therapeutics is a specialty pharmaceutical company that develops and commercializes supportive care products. The Company markets SUBSYS, a sublingual โ€ฆSee details»

INSY - Insys Therapeutics Stock Profile - Barchart.com

Www.insysrx.com P: 480-500-3127. Description: Insys Therapeutics, Inc. is a commercial-stage specialty pharmaceutical company. It is engaged in the development and commercialization of โ€ฆSee details»

Insys Therapeutics, Inc. - Employees, Contact info, Overview - Wiza

May 1, 2024 View info about Insys Therapeutics, Inc. (insysrx.com). Insys Therapeutics, Inc. is a company located in Chandler, Arizona, United States. Find employees, official ...See details»

Insys Therapeutics, Inc. Company Overview, Contact Details ...

[email protected]: 50%. See more formats. Frequently Asked Questions Where is Insys Therapeutics, Inc. 's headquarters located? Insys Therapeutics, Inc. 's main headquarters is โ€ฆSee details»

Insys Therapeutics Inc. - Company Contact Details | Seamless.AI

Insys Therapeutics Inc.โ€™s official website is insysrx.com. What is Insys Therapeutics Inc.โ€™s Revenue? Insys Therapeutics Inc.โ€™s revenue is $100M - $500M. How many employees are โ€ฆSee details»

Insys Therapeutics - Products, Competitors, Financials, Employees ...

May 2, 2013 Insys Therapeutics is a commercial-stage specialty pharmaceutical company that develops and commercializes supportive care products, with a focus on utilizing its formulation โ€ฆSee details»

NeoPharm, Inc. Completes Merger with Insys Therapeutics, Inc.

Nov 9, 2010 For additional inquiries, please contact Michael Babich at (602) 910-2617. About NeoPharm, Inc. NeoPharm, Inc., based in Lake Bluff, Illinois, is a biopharmaceutical company โ€ฆSee details»

Insys Therapeutics, Inc. - VentureRadar

Similar Companies: Heron Therapeutics, Inc. USA Publicly Traded Heron Therapeutics, Inc. is a commercial-stage biotechnology company focused on improving the lives of patients by โ€ฆSee details»

Insys Therapeutics, Inc. email format and employees. - Skrapp.io

Company Directory / Insys Therapeutics, Inc.. Insys Therapeutics, Inc. email format, email addresses of leads and decision-makers, and company information. BackSee details»

Insys, the Opioid Drug Maker, Files for Bankruptcy

Jun 10, 2019 The opioid manufacturer Insys Therapeutics filed for bankruptcy protection Monday, days after agreeing to pay $225 million to settle a federal investigation into the โ€ฆSee details»

NeoPharm, Inc. Completes Merger with Insys Therapeutics, Inc.

Nov 9, 2010 NeoPharm, Inc. (Other OTC: NEOL.PK), a biopharmaceutical company dedicated to the research, development and commercialization of new and innovative thSee details»

FDA Grants INSYS Therapeutics โ€˜Fast Trackโ€™ Designation for

Aug 30, 2018 CONTACT: Corporate Communications: Investor Relations Joe McGrath: Jackie Marcus or Chris Hodges INSYS Therapeutics: Alpha IR Group 480-500-3101: 312-445-2870See details»